The table below shows FATE THERAPEUTICS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$6.65M
$13.63M
$63.53M
$96.30M
$55.85M
$31.43M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$107.83M
$135.00M
$172.60M
$320.45M
$215.52M
$125.62M
SG&A
FATE annual revenue (10-K history)
FATE THERAPEUTICS INC reported annual revenue of $6.65M for fiscal year 2025. That is down 51.2% from $13.63M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $4.40M (FY 2016) to $6.65M. Figures come from the company's audited annual reports as filed with the SEC.